Peng Li

8.0k total citations · 1 hit paper
195 papers, 6.4k citations indexed

About

Peng Li is a scholar working on Molecular Biology, Cancer Research and Plant Science. According to data from OpenAlex, Peng Li has authored 195 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 28 papers in Cancer Research and 20 papers in Plant Science. Recurrent topics in Peng Li's work include Metabolomics and Mass Spectrometry Studies (13 papers), Analytical Chemistry and Chromatography (13 papers) and MicroRNA in disease regulation (12 papers). Peng Li is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (13 papers), Analytical Chemistry and Chromatography (13 papers) and MicroRNA in disease regulation (12 papers). Peng Li collaborates with scholars based in China, Macao and United States. Peng Li's co-authors include Jian‐Bo Wan, Chengwei He, Hu Y, Huanxing Su, Peter P. Roller, Renxiao Wang, Xueliang Fang, York Tomita, Zaneta Nikolovska‐Coleska and Shaomeng Wang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Peng Li

183 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma

2021 231 citations Peng Li et al. profile →

Peers

Peng Li

ONCOL

SURGE

Dongwei Zhang China

Gianfranco Pintus Italy

Eun‐Jung Park South Korea

Zhuo Zhang China

Simone Reuter United States

Yan Qi China

Lina Xu China

Dongming Xing China

Xi Zheng China

Nam Deuk Kim South Korea

Dongwei Zhang China

Peng Li

4.0k ×1.2

638 ×0.9

1.1k ×1.7

ONCOL

678 ×1.1

375 ×0.8

SURGE

Citations per year, relative to Peng Li Peng Li (= 1×) peers Dongwei Zhang

Countries citing papers authored by Peng Li

Since Specialization

Citations

This map shows the geographic impact of Peng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Li more than expected).

Fields of papers citing papers by Peng Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Li. The network helps show where Peng Li may publish in the future.

Co-authorship network of co-authors of Peng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Li. A scholar is included among the top collaborators of Peng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Li. Peng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Ruiqiang, Jiaolin Zhou, Peng Li, et al.. (2025). Personalizing colorectal Cancer treatment: Chemotherapy drug testing with patient-derived tumor cell clusters. Translational Oncology. 61. 102518–102518.

Wang, Yiqiao, Shihao Huang, Ying Cai, et al.. (2025). Programmed cell death protein 5 inhibits hepatocellular carcinoma progression by inducing pyroptosis through regulation of TGF-β/Smad2/3/Snail pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167696–167696.

Cai, Jihai, Sheng Gong, Shuangpeng Wang, et al.. (2024). Sustainable solar-driven interfacial evaporation-photocatalytic degradation of Cu-ZIF-67/rGO/PVA aerogel: A multifunctional material for pollutant treatment. Chemical Engineering Journal. 505. 159130–159130. 7 indexed citations

Cheng, Zehua, Ting Wang, Mai Luo, et al.. (2024). A new luminescent nickel nanocluster with solvent and ion induced emission enhancement toward heavy metal analysis. Biosensors and Bioelectronics. 264. 116660–116660. 6 indexed citations

Li, Peng, et al.. (2024). Discovery of New Compound Comazaphilone I from Mycolicibacterium aurum. Chemistry of Natural Compounds. 60(5). 831–834. 1 indexed citations

Yang, Lixian, Peng Li, Yongshi Jia, et al.. (2024). High-accuracy crRNA array assembly strategy for multiplex CRISPR. Molecular Therapy — Nucleic Acids. 36(1). 102428–102428. 2 indexed citations

Yu, Shuanbao, Yang Yang, Zeyuan Wang, et al.. (2024). CT-based conventional radiomics and quantification of intratumoral heterogeneity for predicting benign and malignant renal lesions. Cancer Imaging. 24(1). 130–130. 3 indexed citations

Li, Peng, et al.. (2023). pH-responsive bufadienolides nanocrystals decorated by chitosan quaternary ammonium salt for treating colon cancer. International Journal of Biological Macromolecules. 242(Pt 2). 124819–124819. 17 indexed citations

Li, Peng, Weiqiang Zhan, Dong Xie, et al.. (2023). Exosome-like Nanovesicles Derived from the Mucilage of Pinctada Martensii Exhibit Antitumor Activity against 143B Osteosarcoma Cells. ACS Applied Materials & Interfaces. 15(22). 26227–26240. 7 indexed citations

10.

Li, Peng, et al.. (2023). Mechanical thrombectomy for acute ischemic stroke with large vessel occlusion in pregnancy with mechanical heart valves： A case report. Heliyon. 9(8). e18616–e18616.

11.

Li, Peng, et al.. (2023). Unraveling the Role of GPX4 Pathway in Ferroptosis and its Implications for Gastric Cancer Management. Journal of Biomedical Research & Environmental Sciences. 4(12). 1692–1696. 1 indexed citations

12.

Cui, Xiping, Jian Lü, Jinchao Wei, et al.. (2023). Single-chain variable fragment-based immunoassay for bioactive natural products. Phytochemistry Reviews. 2 indexed citations

13.

Chen, Huijie, et al.. (2021). Protective effects of selenium yeast against cadmium-induced necroptosis through miR-26a-5p/PTEN/PI3K/AKT signaling pathway in chicken kidney. Ecotoxicology and Environmental Safety. 220. 112387–112387. 40 indexed citations

14.

Li, Peng, et al.. (2019). Identification of Eight Small Nucleolar RNAs as Survival Biomarkers and Their Clinical Significance in Gastric Cancer. Frontiers in Oncology. 9. 788–788. 17 indexed citations

15.

Ung, Carolina Oi Lam, Vivian Lee, Hu Y, et al.. (2017). Community pharmacists’ perceptions about pharmaceutical service of over-the-counter traditional Chinese medicine: a survey study in Harbin of China. BMC Complementary and Alternative Medicine. 17(1). 9–9. 24 indexed citations

16.

Refaat, Alaa, Paras Jawaid, Mati Ur Rehman, et al.. (2017). Hyperthermia and radiation reduce the toxic side-effects of bufadienolides for cancer therapy. Oncology Letters. 14(1). 1035–1040. 10 indexed citations

17.

Feng, Ruibing, Meng Wang, Chunyan Yan, et al.. (2016). Endogenous n‐3 Fatty Acids Alleviate Carbon‐Tetrachloride‐Induced Acute Liver Injury in Fat-1 Transgenic Mice. Oxidative Medicine and Cellular Longevity. 2016(1). 7962948–7962948. 19 indexed citations

18.

Wang, Liang, Jian Li, Hu Y, et al.. (2016). An Investigation into Traditional Chinese Medicine Hospitals in China: Development Trend and Medical Service Innovation. SSRN Electronic Journal.

19.

Li, Peng, Zhujun Zhang, Qingliang Wang, et al.. (2009). The ectopic expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells. International Immunopharmacology. 9(7-8). 1002–1009. 15 indexed citations

20.

Li, Peng, et al.. (2008). In vivo optical imaging of human lymphoma xenograft using a library-derived peptidomimetic against α4β1 integrin. Molecular Cancer Therapeutics. 7(2). 432–437. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact